The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
May 31st 2024
The priority review of inavolisib is for treatment of patients with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
Statins May Reduce Mortality Risk in Prostate Cancer Patients
November 12th 2013Risk of death from prostate cancer was reduced for patients who started taking statins after being diagnosed with the disease and was reduced even more for those who started taking statins before being diagnosed.
Read More